| abstract |
The present invention relates to a method for detecting allogeneic therapeutic cells in blood (such as human umbilical cord tissue-derived cells (hUTC)). The method includes identifying one or more markers that are positive for a homologous therapeutic cell (e. G., HUTC) and one or more markers that are positive for human peripheral blood mononuclear cells (PBMC); Providing a blood sample from a patient treated with an allogeneic therapeutic cell (e. G., HUTC), one or more markers positive for PBMC and one or more markers positive for allogeneic therapeutic cells (e. G., HUTC) Analyzing the sample using an analyzing method for detecting the sample; And PBMCs and one or more markers that are positive for allogeneic therapeutic cells (e. G., HUTC). In one embodiment, the cell is hUTC, the markers positive for hUTC include CDlO and / or CDl3, and the one or more markers positive for PBMC comprise CD45. |